GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Novo Nordisk partners with OpenAI to accelerate drug discovery using AI across research manufacturing and operations globally ...

Alex Bores is trying to win a congressional seat to represent part of New York City. Here’s why A.I. executives are funding ...

OpenAI is granting a select group of users access to a new artificial intelligence model designed to identify software security vulnerabilities. This strategic move comes just one week after rival ...

OpenAI is releasing a new version of its Codex desktop app today. The latest Codex update adds three key features that expand ...

OpenAI Has a New AI Model Built for Biology and Science ...

Two studies put ChatGPT, Gemini and others to the test on questions of health. Their assessment? “A bit of a shock.” ...

AI giant said its security system has already contributed to more than 3,000 vulnerability fixes since its private beta ...

Cyber, a fine-tuned variant of its GPT-5.4 model designed for defensive cybersecurity work and also announced a significant ...

Danish drugmaker Novo Nordisk is partnering with ChatGPT's parent company, OpenAI, to bring ‘better treatment options’ for ...

OpenAI rolled out their updated Codex app for Mac yesterday and, among other things, they shipped a native computer use tool ...

The latest boom in robotics represents a revolution in the way machines have learned to interact with the world.